April 4, 2024

UF team plays major role in success of newly approved Duchenne muscular dystrophy drug

Duchenne muscular dystrophy families, advocates and health care providers celebrated a milestone in March with the U.S. Food and Drug Administration’s approval of the first nonsteroidal drug for the treatment of Duchenne.

April 3, 2023

UF Conference Draws Muscle Biology Experts and Trainees from Around the World

Nearly 400 participants from North and South America, Europe, and Asia gathered at the University of Florida March 15-17 for Advances in Skeletal Muscle Biology, the world’s premier conference focused on adult skeletal muscle biology.

February 1, 2021

New $6.25 Million Grant Allows UF to Expand 10-Year Study of Muscular Dystrophy Disease Progression

ImagingDMD can now continue to put their efforts towards the study of Duchenne muscular dystrophy and MRI biomarkers and expand their efforts into Becker muscular dystrophy due to a recent grant from the National Institutes of Health.

January 20, 2021

UF researchers see promising results in study of investigational treatment for Duchenne muscular dystrophy

Using innovative methods to measure changes in muscle, a team has shown that after treatment three young boys with DMD had considerably lower fat infiltration in their muscles than boys receiving standard treatment.

March 6, 2020

Myology Institute Inaugural Retreat and Marty Kushmerick Memorial Lecture

The Myology Institute hosted its inaugural members retreat and Marty Kushmerick Memorial Lecture on Friday, March 6th. For those who were not able to attend, please click the link below to view the lecture.

April 25, 2019

Should Athletes Be Allowed to Enhance Their Genes

So-called gene doping is banned in sports, but some philosophers argue that it’s the way of the future

March 12, 2019

World's Muscle Biology Experts Gather at UF Conference

Researchers from across the globe gathered in the Reitz Union at the University of Florida for a three-day muscle biology conference last week.

September 1, 2018

Muscle Clocks Play a Role in Regulating Metabolism

Just 20 years ago, scientists didn’t even realize muscles had their own circadian clocks. Now they are beginning to appreciate their importance in health.

May 21, 2018

Potential Breakthrough in the Treatment of Duchenne Muscular Dystrophy

At the American Academy of Neurology 70th Annual meeting in Los Angeles on April 25, it was reported that the drug edasalonexent showed a remarkably favorable impact on the progression of Duchenne muscular dystrophy in 4- to 7-year-old boys (“MoveDMD trial”).

April 17, 2017

Drug pair slows progression of muscular dystrophy in animal models

A pair of protein-inhibiting compounds is effective at slowing the progression of a form of muscular dystrophy in animal models, a group of University of Florida Health researchers has found.

April 5, 2017

UF conference attracts world’s leading muscle biology researchers

The University of Florida welcomed more than 300 researchers from around the world for the Advances in Skeletal Muscle Biology in Health and Disease conference March 8-10 in Gainesville

December 14, 2016

NIH grants aim to understand molecular changes during physical activity

When we exercise, a cascade of benefits occurs, but researchers don’t know exactly what happens in the body to cause those benefits. Now, two teams at the University of Florida have received a total of approximately $11.6 million out of a $170 million push from the National Institutes of Health to study the molecular changes that occur during physical activity.

April 18, 2016

Building the research of muscle

A year after it was formed, the UF Myology Institute is gaining strength in the world of muscle biology research.

August 24, 2015

Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center at UF Health

University of Florida Health has been designated by the National Institutes of Health as one of six centers to help translate scientific findings into strategies to improve the lives of muscular dystrophy patients. UF Health has received first-year funding of a 5-year, $10.76 million grant to study ways to address muscle degeneration caused by the disease.

December 9, 2014

H. Lee Sweeney, Ph.D. joins the Department of Pharmacology as The Thomas H. Maren, M.D., Eminent Scholar Chair

The Department of Pharmacology is honored to welcome Dr. H. Lee Sweeney to the faculty. Dr. Sweeney will join the department as The Thomas H. Maren, M.D., Eminent Scholar Chair. Dr. Sweeney will also serve as Director of the UF Myology Institute.